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Abstract Activation of the mechanistic/mammalian target of rapamycin (mTOR) kinase in models
of acute and chronic pain is strongly implicated in mediating enhanced translation and
hyperalgesia. However, the molecular mechanisms by which mTOR regulates nociception remain
unclear. Here we show that deletion of the eukaryotic initiation factor 4E-binding protein 1 (4E-
BP1), a major mTOR downstream effector, which represses eIF4E activity and cap-dependent
translation, leads to mechanical, but not thermal pain hypersensitivity. Mice lacking 4E-BP1 exhibit
enhanced spinal cord expression of neuroligin 1, a cell-adhesion postsynaptic protein regulating
excitatory synapse function, and show increased excitatory synaptic input into spinal neurons, and
a lowered threshold for induction of synaptic potentiation. Pharmacological inhibition of eIF4E or
genetic reduction of neuroligin 1 levels normalizes the increased excitatory synaptic activity and
reverses mechanical hypersensitivity. Thus, translational control by 4E-BP1 downstream of mTOR
effects the expression of neuroligin 1 and excitatory synaptic transmission in the spinal cord, and
thereby contributes to enhanced mechanical nociception.
DOI:10.7554/eLife.12002.001
Introduction
De novo gene expression induced by noxious stimuli markedly contributes to the development of
pain hypersensitivity (i.e., allodynia and hyperalgesia). Regulation of gene expression at the level of
translation enables the cell to rapidly change its proteome by modulating the rate of mRNA transla-
tion without altering mRNA levels (Sonenberg and Hinnebusch, 2009). Upregulation of mRNA
translation via activation of the mechanical/mammalian target of rapamycin (mTOR) by noxious stim-
uli has been proposed to sensitize primary nociceptors and spinal circuits (Bogen et al., 2012;
Ferrari et al., 2013; Jimenez-Diaz et al., 2008; Melemedjian et al., 2010; Obara and Hunt, 2014;
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Price and Geranton, 2009). mTOR is an evolutionarily conserved serine/threonine kinase that con-
trols cell homeostasis through key molecular processes including translation, lipid biogenesis,
autophagy, and cytoskeleton organization (Shimobayashi and Hall, 2014). mTOR is the catalytic
subunit of two structurally and functionally distinct multiprotein complexes, mTORC1 and mTORC2
(Lipton and Sahin, 2014). mTORC1 is defined by the protein raptor and is sensitive to rapamycin,
while mTORC2 is defined by the protein rictor and is rapamycin insensitive. mTORC1 is a key regula-
tor of translation, whereas mTORC2 controls the actin cytoskeleton (Jacinto et al., 2004;
Sarbassov et al., 2004). The mTORC1 pathway is activated in primary nociceptors and superficial
dorsal horn neurons in rodent models of inflammatory pain (Jiang et al., 2013; Liang et al., 2013;
Norsted Gregory et al., 2010; Xu et al., 2011), bone cancer-induced pain (Shih et al., 2012), neu-
ropathic pain (Zhang et al., 2013), and in response to repeated morphine administration (Xu et al.,
2015; Xu et al., 2014). The functional role of mTORC1 activation has been studied using the
mTORC1 specific inhibitor, rapamycin, and its derivatives (rapalogues). Systemic or intrathecal (i.t.)
administration of rapalogues does not affect acute responses to mechanical and thermal stimuli
(Geranton et al., 2009; Xu et al., 2014), but it reduces nocifensive behaviors, and normalizes
mechanical hypersensitivity in rodent models of inflammatory pain (Asante et al., 2009; Jiang et al.,
2013; Price and Geranton, 2009; Price et al., 2007), bone cancer-induced pain (Shih et al., 2012),
and neuropathic pain (Asante et al., 2010; Cui et al., 2014; Zhang et al., 2013). Taken together,
these findings indicate that noxious stimuli-induced activation of mTORC1 plays an important role in
the development of pain hypersensitivity. However, the cellular and molecular mechanisms mediat-
ing the effect of mTORC1 on nociception are not known.
All nuclear transcribed eukaryotic mRNAs harbor, at their 5’ end, the structure m7GpppN (where
N is any nucleotide) termed ‘cap’, which facilitates ribosome recruitment to the mRNA. Recruitment
of the ribosome to the mRNA is primarily regulated at the initiation step. A critical step of this pro-
cess is the assembly of the eukaryotic initiation factor 4F (eIF4F) complex, which consists of eIF4E,
the cap binding protein subunit, eIF4G, a large scaffold protein, and eIF4A, an RNA helicase that
unwinds the mRNA 5’ UTR (untranslated region) secondary structure. Because eIF4E generally
eLife digest Despite the unpleasant feeling it causes, pain is necessary for survival as it helps
individuals to avoid objects, environments and situations that cause damage to their body. However,
millions of people experience long-lasting “chronic” pain, or are hypersensitive to pain. There are
few treatments available for these conditions, but these treatments do not work well for the majority
of patients, and can have serious side effects. To develop new treatments, researchers must first
better understand how chronic pain develops.
Pain is transmitted to the brain in the form of electrical signals “fired” along nerve fibers.
Different nerves transmit information about different types of pain: for example, pain caused by a
sharp object pressed against the skin activates a different set of neurons to those activated when
touching something dangerously hot. Studies in mice have suggested that a protein called mTOR
that is found inside neurons is important for them to fire pain signals. However, it is not clear exactly
how mTOR contributes to pain signaling, although it is known to affect the activities of several other
proteins in neurons.
One protein that mTOR affects the activity of is called 4E-BP1. Now, Khoutorsky, Bonin, Sorge
et al. show that mice that lack 4E-BP1 behave in ways that suggest they are hypersensitive to poking
or pinching sensations. However, the mice did not show hypersensitivity when they touched a hot
surface. Further investigation revealed that the neurons in the spinal cord of mice that lack 4E-BP1
produce abnormally high amounts of a molecule called neuroligin 1, which makes the neurons more
likely to fire and thus signal pain.
Khoutorsky, Bonin, Sorge et al. found that treating mice that lack 4E-BP1 with a compound that
reduces neuroligin 1 production causes their neurons to fire more normally. This also reduces the
animals’ apparent signs of hypersensitivity to pressure on their skin. It will be important in future
studies to identify additional targets of 4E-BP1 in the spinal cord that could contribute to increased
mechanical sensation, and also to study the role of 4E-BP1 in peripheral nerves.
DOI:10.7554/eLife.12002.002
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exhibits the lowest expression level of all eukaryotic initiation factors, the cap-recognition step is
rate-limiting for translation and a major target for regulation (Sonenberg and Hinnebusch, 2009).
mTORC1 is a key regulator of translation initiation via phosphorylation of its downstream targets,
eIF4E-binding proteins (4E-BPs) and p70S6 kinases (S6Ks). In their hypo-phosphorylated form, 4E-
BPs compete with eIF4G for binding to eIF4E to repress eIF4F complex assembly, and thereby trans-
lation initiation. Following phosphorylation by mTORC1, 4E-BPs dissociate from eIF4E, allowing for
eIF4F complex formation and activation of translation (Gingras et al., 1996). Three 4E-BP isoforms
(1, 2, and 3) have similar functions, differing in their tissue distribution. 4E-BP3 expression is limited
to few tissues, and is excluded from the nervous system. In the forebrain, 4E-BP2 is the major iso-
form, and 4E-BP2 knockout mice exhibit enhanced excitation (Gkogkas et al., 2013; Ran et al.,
2013), alterations in synaptic plasticity, memory (Banko et al., 2007; Banko et al., 2005), and social
behavior (Gkogkas et al., 2013). In the suprachiasmatic nucleus, 4E-BP1 controls circadian clock
functions via regulation of vasoactive intestinal polypeptide (Vip) mRNA translation (Cao et al.,
2013). In the pain pathway, 4E-BP1 is expressed in neurons in the dorsal horn of the spinal cord,
and in peripheral nerves (Jimenez-Diaz et al., 2008; Melemedjian et al., 2011), whereas in
the dorsal root ganglion (DRG) it was detected only in satellite glial cells (Xu et al., 2010).
Decreasing S6Ks activity by either pharmacological inhibitors or S6K1/2 null mutation unexpect-
edly led to mechanical allodynia via activation of ERK, a well-known pain sensitizing molecule
(Melemedjian et al., 2013). Activation of ERK is caused by disinhibition of the S6K1/IRS-1/ERK nega-
tive feedback loop (Carracedo et al., 2008). Here, we investigated the role of the other major
mTORC1 downstream effectors, 4E-BPs, in nociception using Eif4ebp1 and 2 knockout (Eif4epb-/-)
mice. Removal of 4E-BP1 and 2 relieves eIF4E suppression and provides an opportunity to study cel-
lular and molecular mechanisms underlying the impact of mTORC1, via 4E-BPs, on nociception. Pre-
vious work showed that intraplantar administration of two well-known sensitizers of nociceptors, IL-6
and NGF, upregulates eIF4F complex formation and cap-dependent translation in primary afferent
neurons (Melemedjian et al., 2010). Peripheral inhibition of eIF4F with a specific inhibitor, 4EGI-1,
completely blocked IL-6- and NGF-induced mechanical allodynia, supporting the idea that enhanced
eIF4F complex formation and cap-dependent translation contribute to sensitization of primary affer-
ents. However, the roles of eIF4F and 4E-BPs in the regulation of spinal circuits are unknown. Here
we show that Eif4ebp1-/-, but not Eif4ebp2-/- mice exhibit mechanical (but not thermal) hypersensitiv-
ity, which can be rescued by intrathecal administration of 4EGI-1. Mechanical hypersensitivity is also
elicited by downregulation of 4E-BP1 in the spinal cord dorsal horn. In Eif4ebp1-/- mice, the excit-
atory synaptic input into spinal neurons is enhanced and the threshold for potentiation of electri-
cally-evoked field post-synaptic potentials (fPSPs) in the superficial dorsal horn is lowered. The
enhancement of excitatory synaptic transmission is mediated via increased synthesis of neuroligin 1,
which promotes the excitatory synapse function. Reduction of neuroligin 1 levels in Eif4ebp1-/- mice
normalizes excitatory synaptic transmission, and partially reverses mechanical allodynia. Collectively,
our data demonstrate that de-repression of eIF4E, via removal of 4E-BP1, contributes to mechanical
allodynia through a neuroligin 1-mediated increase in the excitatory synaptic drive to the spinal cir-
cuit, and provides a new paradigm to explain the mechanisms by which mTORC1 controls
nociception.
Results
4E-BP1 ablation induces mechanical hypersensitivity
To study the role of 4E-BPs and eIF4F in nociception, we assessed mechanical and thermal sensation
in Eif4ebp1-/-, Eif4ebp2-/-, and Eif4ebp1-/-/2-/- mice and wild-type controls. Eif4ebp1-/- mice exhib-
ited a marked increase in mechanical sensation in von Frey and tail clip tests (45% decrease in with-
drawal threshold and 52% reduction in latency to attack tail clip, respectively, Figure 1A), whereas
their thermal sensitivity was unaffected in both the radiant heat paw-withdrawal and hot-plate tests
(Figure 1B). Additionally, in the chemical/inflammatory formalin test (20 ml, 0.5% formalin, intraplan-
tar) Eif4ebp1-/- mice showed higher levels of nocifensive behavior (Figure 1C) and increased c-Fos
expression in the dorsal horn of the lumbar spinal cord (Figure 1D). In contrast, Eif4ebp2-/- mice
showed no mechanical (von Frey and tail clip tests, Figure 1—figure supplement 1A) or thermal
pain phenotype (radiant heat paw-withdrawal and hot-plate tests, Figure 1—figure supplement
Khoutorsky et al. eLife 2015;4:e12002. DOI: 10.7554/eLife.12002 3 of 18
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Figure 1. Eif4ebp1-/- mice exhibit mechanical hypersensitivity and increased formalin response. Mechanical pain sensitivity is increased in Eif4ebp1-/-
mice as evident by decreased von Frey thresholds (A, n=8/genotype) and shortened latencies to attack tail clip (A, n=8/genotype), whereas thermal
sensitivity is not altered (B, n=8/genotype). (C) Eif4ebp1-/- mice show more nocifensive (licking/shaking) behavior of the injected hind paw than their
wild-type (WT) littermates in the formalin test (0.5%, 20 ml, n=8/genotype). Changes in paw weight, indicative of formalin-induced inflammation, were
not different in Eif4ebp1-/- mice (not shown). (D) Intraplantar injection of formalin (0.5%, 20 ml) induced an enhanced upregulation of c-Fos (2 h post
injection) in superficial layers (I-II) of the lumbar spinal cord of Eif4ebp1-/- as compared to WT mice (n=3 mice/group, 10 sections/mouse). (E) Western
blot analysis of lysates prepared from the dorsal horn of the lumbar spinal cord and L3/L4 DRGs seven days post intraparenchymal dorsal horn injection
of lentiviruses expressing shRNA against Eif4ebp1 as compared to non-targeting (scrambled) shRNA (n=3/condition). Mice injected with shRNA against
Eif4ebp1 exhibit a reduction in von Frey threshold 7 days post injection (F, n=9/condition), whereas thermal sensitivity is not altered (G, n=9/condition).
Data are presented as mean ± SEM. *p<0.05, **p<0.01, ***p<0.001, ns–not significant by Student’s t-test or t-test following repeated measures
ANOVA. Scale bar: 100 mm. See also figure supplement 1 and 2.
DOI: 10.7554/eLife.12002.003
The following figure supplements are available for Figure 1:
Figure supplement 1. Eif4ebp1/2 DKO mice, but not Eif4ebp2-/-, mice exhibit mechanical hypersensitivity and enhanced formalin responding.
DOI: 10.7554/eLife.12002.004
Figure 1. continued on next page
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1B), and no alterations in formalin test behavior (Figure 1—figure supplement 1C). Mice lacking
both 4E-BP1 and 4E-BP2 (Eif4ebp1-/-/2-/-) showed mechanical hypersensitivity and increased pain
behavior in formalin test (Figure 1—figure supplement 1D–F), a phenotype identical to Eif4ebp1-/-
mice. We did not detect any reorganization of the dorsal horn of Eif4ebp1-/- mice as assessed by
neuronal marker NeuN (Figure 1—figure supplement 2A), projection of peptidergic (expressing
substance P (SP) and calcitonin gene-related peptide (CGRP), Figure 1—figure supplement 2B,C)
or non-peptidergic (expressing isolectin B4 (IB4), Figure 1—figure supplement 2D) C fibers, distri-
bution of glial marker glial fibrillary acidic protein (GFAP, Figure 1—figure supplement 2E), and
5HT3A receptor (HTR3A, Figure 1—figure supplement 2F). To exclude the possibility that the phe-
notypes observed in Eif4ebp1-/- animals were the result of long-term developmental compensations
and to test the role of 4E-BP1 selectively in the spinal cord, we knocked down Eif4ebp1 in the dorsal
horn of adult wild-type mice using an intraparenchymal injection of lentivirus expressing shRNA
against Eif4ebp1. The virus-driven eGFP expression was restricted to the dorsal horn and showed
mostly neuronal localization (Figure 1—figure supplement 3). Seven days after injection of Eif4ebp1
shRNA into the dorsal horn of the lumbar spinal cord, mice showed reduced levels of 4E-BP1 protein
in the lumbar spinal cord (53 ± 9% reduction, Figure 1E), but not in DRGs, and exhibited mechani-
cal, but not thermal hypersensitivity (Figure 1F–G). To study the distribution of 4E-BP1 and 4E-BP2,
we performed western blot analysis of proteins prepared from DRG and superficial spinal cord,
which showed the presence of 4E-BP1, but much less of the 4E-BP2 isoform (Figure 1—figure sup-
plement 2G). Taken together, our data demonstrate that 4E-BP1 is the predominant functional iso-
form in the pain pathway and its downregulation in the spinal cord elicits mechanical
hypersensitivity.
4E-BP1 suppresses eIF4F complex formation by competing with eIF4G for binding to eIF4E. Thus,
removal of 4E-BP1 leads to increased levels of the eIF4F complex (Gkogkas et al., 2013;
Pause et al., 1994; Tahmasebi et al., 2014). Therefore, we measured eIF4F complex levels in
Eif4ebp1-/- mice using a cap-binding assay (see experimental procedures). As expected, in the lum-
bar spinal cord lysates, the amount of eIF4G associated with the cap-bound eIF4E was higher in
Eif4ebp1-/- mice as compared to wild-type mice (Figure 2A). Next, we used an inhibitor of the eIF4F
complex, 4EGI-1, which binds to eIF4E and inhibits its interaction with eIF4G. Daily i.t. administration
of low doses of 4EGI-1 (10 mg) over three days normalized the enhanced binding of eIF4G to eIF4E
in Eif4ebp1-/- mice (Figure 2A), and rescued the mechanical hypersensitivity and enhanced formalin-
induced pain behavior in these mice (Figure 2B–C). These data indicate that the mechanical sensitiv-
ity and increased responses in the formalin test in Eif4ebp1-/- mice are a consequence of augmented
eIF4F complex formation.
Next, we investigated the molecular and cellular mechanisms underlying the mechanical hyper-
sensitivity of Eif4ebp1-/- mice. We focused on spinal mechanisms by which 4E-BP1 controls mechani-
cal sensitivity. mTOR and 4E-BPs are strongly implicated in the regulation of synaptic transmission
and synaptic plasticity in pyramidal hippocampal neurons (Gkogkas et al., 2013; Ran et al., 2013;
Richter and Klann, 2009; Santini et al., 2013; Weston et al., 2012). Thus, we measured spontane-
ous miniature excitatory and inhibitory postsynaptic inputs into lamina II spinal neurons in spinal
cord slices prepared from Eif4ebp1-/- and wild-type mice. The amplitude of miniature excitatory
postsynaptic currents (mEPSCs) was increased in spinal neurons in Eif4ebp1-/- as compared to wild-
type slices, whereas there was no statistically significant change in mEPSC frequency (Figure 3A).
The amplitude and frequency of inhibitory postsynaptic currents (mIPSC) were increased in
Eif4ebp1-/- mice (Figure 3B). In the spinal cord, fast inhibitory synaptic transmission is mediated via
GABA and glycine receptors. Interestingly, while glycinergic mIPSC amplitude and frequency were
enhanced, no alterations were measured in GABAA-mediated synaptic transmission (Figure 3C). The
increase in the mEPSC amplitude in lamina II spinal neurons of Eif4ebp1-/- was reversed by i.t. admin-
istration of 4EGI-1 (10 mg, daily for 3 days, Figure 3D), however, 4EGI-1 had no effect on the
Figure 1. Continued
Figure supplement 2. No gross alterations in the dorsal horn of the Eif4ebp1-/- mice.
DOI: 10.7554/eLife.12002.005
Figure supplement 3. Distribution of lentivirus-driven eGFP expression.
DOI: 10.7554/eLife.12002.006
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increased amplitude and frequency of mIPSC (Figure 3E). The reasons for these differences will be
addressed in the Discussion.
Additionally, we measured potentiation of fPSPs in Eif4ebp1-/-and wild-type lumbar spinal cords
by stimulating dorsal roots (2 Hz) and recording extracellular fPSPs in the superficial layer of the spi-
nal cord. The threshold for induction of potentiation was lowered in Eif4ebp1-/- as compared to
wild-type mice, since potentiation was elicited with 40 s of stimulation in Eif4ebp1-/- spinal cords,
whereas in wild-type spinal cords 60 s of stimulation were required to potentiate EPSPs (Figure 3F).
The extent of potentiation achieved with 60 s of stimulation was 37.5% higher in Eif4ebp1-/- as com-
pared to wild-type spinal cords. Together, the results demonstrate that basal synaptic transmission
is enhanced, and the threshold for induction of synaptic potentiation is lowered in Eif4ebp1-/- mice.
Based on the effects of translational de-repression on synaptic physiology, as a consequence of
4E-BP1 depletion, we reasoned that translation of specific mRNAs, which regulate synaptic transmis-
sion, is affected. Consistent with previous reports, e.g. Tahmasebi et al., 2014, we found no differ-
ences in rates of general translation between wild-type and Eif4ebp1-/- mice, using the puromycin
incorporation assay (Figure 4A), supporting the idea that alterations in translation of a small subset
Figure 2. Increased levels of eIF4F complex in Eif4ebp1-/- mice cause mechanical hypersensitivity and increased formalin response. (A) Left,
Immunoblot analysis of cap column pull-down proteins prepared from the spinal cord of Eif4ebp1-/- and wild-type mice (WT) treated with 4EGI-1 (10
mg, i.t. once a day for 3 days) or vehicle. Right, quantification of eIF4G1 in cap column pull-down material (n=4/genotype/drug). (B) Chronic 4EGI-1
treatment rescues mechanical hypersensitivity of Eif4ebp1-/- mice. von Frey threshold was measured prior to (baseline) and after 4EGI-1 chronic
treatment (10 mg, i.t., once a day for 3 days, n=8/genotype/drug). (C) Chronic 4EGI-1 treatment normalizes the enhanced nocifensive (licking/shaking)
behavior of Eif4ebp1-/- mice during the early (0–10 min post-formalin, 0.5%) and late phases (10–60 min post-formalin) of the formalin test (n=8/
genotype/drug). Data are presented as mean ± SEM. *p<0.05, **p< 0.01 by Student’s t-test following two-way (genotype x drug) ANOVA (in A, C) or
following two-between (genotype, drug), one-within (repeated measures) ANOVA (in B).
DOI: 10.7554/eLife.12002.007
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Figure 3. Excitatory and inhibitory synaptic transmissions are increased in the spinal cord of Eif4ebp1-/- mice. Representative traces (top) of mEPSCs (A)
and mIPSCs (B) from lamina II neurons in acute lumbar spinal cord slices from Eif4ebp1-/- and wild-type mice (WT). Bar graphs (bottom) show mEPSC
(A) and mIPSC (B) amplitude, frequency and synaptic total charge transfer (A: n=8 WT; n=7 Eif4ebp1-/-; B: n=9 WT; n=7 Eif4ebp1-/-). (C) To isolate
GABAA or glycinergic mIPSCs, strychnine (STRY, glycine receptor antagonist, 1 mM) or bicuculline (BIC, GABAA receptor antagonist, 10 mM) were used,
respectively. Left: representative traces of mIPSC in the presence of strychnine or bicuculline from Eif4ebp1-/- and WT slices. Right: bar graphs showing
mIPSC amplitude and frequency in the presence of strychnine (n=7 WT; n=8 Eif4ebp1-/-) or bicuculline (n=9 WT; n=8 Eif4ebp1-/-). Eif4ebp1-/- mice were
treated with 4EGI-1 (10 mg, daily for 3 days, i.t.) or vehicle, and the mEPSCs (D) and mIPSCs (E) were recorded from lamina II neurons (n=7 vehicle; n=11
4EGI-1). (F) Synaptic potentiation was elicited by stimulation of the dorsal root (2 Hz) for 20, 40 and 60 s and recording fEPSPs 125 mm from the dorsal
surface of the spinal cord. Synaptic potentiation is induced in Eif4ebp1-/-, but not WT spinal cord preparation, by 40 s stimulation. Left: representative
traces of fEPSPs, evoked by stimulation for the indicated length of time. Right: bar graph showing the summary of synaptic potentiation during the last
5 min prior to stimulation (n=7 WT; n=8 Eif4ebp1-/-). Data are presented as mean ± SEM. *p<0.05, **p<0.01, ***p<0.001 by Student’s t-test (A, B, D, E),
or by Student’s t-test following two-way ANOVA (genotype x drug in C; genotype x duration in F).
DOI: 10.7554/eLife.12002.008
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of mRNAs engender nociceptive phenotypes in Eif4ebp1-/- mice. We previsouly investigated the
mechanisms underlying the enhanced excitatory and inhibitory synaptic transmission in hippocampal
Figure 4. Enhanced expression of neuroligin 1 contributes to mechanical hypersensitivity of Eif4ebp1-/- mice. (A) General translation is not altered in
Eif4ebp1-/- mice as assessed by puromycin incorporation (n=3/genotype). (B) Protein expression of neuroligin (NLGN) 1, 2 and 3 is increased in
synaptosomes prepared from the dorsal horn of the lumbar spinal cord of Eif4ebp1-/- mice (n=5/genotype), whereas their mRNA levels are not changed
(C). (D) Wild-type (WT) and Eif4ebp1-/- mice were treated with 4EGI-1 (10 mg, daily for 3 days, i.t.) or vehicle, and the protein levels of neuroligin 1 were
measured in lysates prepared from the dorsal horn of the lumbar spinal cord using western blot analysis (n=5/condition). (E) Nlgn1-/- mice exhibit
elevated von Frey thresholds, whereas Nlgn1+/- mice show no alteration in mechanical sensitivity (n=10 WT and Nlgn1-/-; n=15 Nlgn1+/-). (F) Deletion of
one allele of Nlgn1 in Eif4ebp1 knockout mice (Eif4ebp1-/- / Nlgn1+/-) normalizes neuroligin 1 protein levels in the dorsal horn of the lumbar spinal cord
of Eif4ebp1-/- mice (left) and partially attenuates mechanical allodynia of Eif4ebp1-/- mice (right, n=10 wild-type, n=7 Eif4ebp1-/-, n=14 Eif4ebp1-/- /
Nlgn1+/-). Data are presented as mean ± SEM. *p<0.05, **p<0.01, ns–not significant, by Student’s t-test (A–C), Bonferroni post-hoc test following two-
between (genotype, condition) one-within (repeated measures) ANOVA (E), or Bonferroni post-hoc test following one-way ANOVA (F).
DOI: 10.7554/eLife.12002.009
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neurons of Eif4ebp2-/- mice (Gkogkas et al., 2013). 4E-BP2 is the major 4E-BP isoform in the hippo-
campus (Banko et al., 2005). Members of the family of post-synaptic adhesion proteins, neuroligins,
were upregulated in the hippocampus of 4E-BP2 depleted mice, leading to changes in synaptic
transmission. Specifically, translation of neuroligin (Nlgn) 1, 2 and 3 mRNAs was increased in the
brain of Eif4ebp2-/- mice. Neuroligin 1 controls excitatory synapse formation, maturation, and func-
tion, whereas neuroligin 2 regulates inhibitory synaptic transmission (Krueger et al., 2012). Neuroli-
gin 3 controls both excitatory and inhibitory synapses. An additional study has revealed a
translational upregulation of a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor
(AMPA) receptor subunits, Glua1 and Glua2 in response to 4E-BP2 ablation (Ran et al., 2013). Pro-
tein levels of neuroligins (1–3) were increased in synaptosomes prepared from Eif4ebp1-/- spinal
cords (Figure 4B), whereas their mRNA levels were unaltered (Figure 4C), suggesting that transla-
tion of neuroligin 1–3 mRNAs is increased in Eif4ebp1-/- mice. No differences in Glua1 and Glua2
protein expression were found in Eif4ebp1-/- spinal cords (Figure 4B).
In light of these results we hypothesized that the increased excitatory synaptic input into the spi-
nal neurons and mechanical hypersensitivity in Eif4ebp1-/- mice are the result of increased neuroligin
1 expression, which is known to strongly promote excitatory synaptic transmission. The enhanced
expression of neuroligin 1 in Eif4ebp1-/- spinal cord was normalized by 4EGI-1 treatment (10 mg,
daily for 3 days, i.t. Figure 4D), consistent with our finding that 4EGI-1 normalizes the increased
mEPSC amplitude in Eif4ebp1-/- spinal neurons (Figure 3D). To study the role of neuroligin 1 in noci-
ception, we examined mice with a null mutation of neuroligin 1. Nlgn1-/- mice showed elevated von
Frey thresholds (Figure 4F), indicating reduced mechanical sensation, whereas heterozygous mice
(Nlgn1+/-) exhibited no change in their mechanical thresholds. Next, we normalized the enhanced
expression of neuroligin 1 in Eif4ebp1-/- mice by removing one allele of Nlgn1. To this end, we gen-
erated Eif4ebp1-/-/ Nlgn1+/- double knockout mice and compared their mechanical sensitivity to
Eif4ebp1-/- littermates. Deletion of one allele of Nlgn1 in Eif4ebp1-/- mice normalized the increased
neuroligin 1 expression (Figure 4G) and reversed mechanical sensitivity (Figure 4G). Taken together,
our data demonstrate that elevated levels of neuroligin 1 contribute to the mechanical hypersensitiv-
ity of Eif4ebp1-/- mice.
Finally, we explored whether the increase in excitatory synaptic transmission in Eif4ebp1-/- mice is
mediated via enhanced expression of neuroligin 1. Strikingly, deletion of one allele of Nlgn1 in
Eif4ebp1-/- mice (Eif4ebp1-/-/Nlgn1+/-) rescued the enhanced excitatory synaptic transmission
(mEPSC amplitude and total charge transfer) in spinal neurons (Figure 5A), but had no effect on the
inhibitory synapses (Figure 5B). No differences were found in input resistance and membrane capac-
itance of spinal neuron between the four genotypes examined (Figure 5—figure supplement 1).
Thus, our data demonstrate that the enhanced expression of neuroligin 1 in mice lacking 4E-BP1
strengthens excitatory spinal synapses, and thereby contributes to mechanical hypersensitivity.
Discussion
mTORC1 stimulates translation by relieving the 4E-BP-mediated block on eIF4F complex formation
and cap-dependent translation. IL-6 and NGF-mediated enhancement of eIF4F complex formation
play an important role in mediating mechanical nociceptive plasticity in primary afferent neurons
(Melemedjian et al., 2010). However, the roles of eIF4F and 4E-BPs in regulation of spinal circuits
remain unknown. Here, we show that de-repression of translation by removal of 4E-BP1 leads to
enhanced eIF4F complex formation in the spinal cord, and to mechanical hypersensitivity and
increased response to noxious chemical/inflammatory stimuli. This effect was observed in both
Eif4ebp1-/- mice and in mice with selective downregulation of 4E-BP1 in the spinal cord dorsal horn.
Normalization of eIF4F complex levels in Eif4ebp1-/- mice by intrathecal administration of 4EGI-1
reversed the exaggerated mechanical sensation, thus demonstrating that the enhanced eIF4F com-
plex is the underlying cause for mechanical hypersensitivity in Eif4ebp1-/- mice.
eIF4F controls translation of a specific subset of mRNAs. Consistent with this and with previous
reports (Gkogkas et al., 2013; Tahmasebi et al., 2014), we found that general translation is not
altered in Eif4ebp1-/- mice (Figure 4A), indicating that upregulated translation of certain mRNAs
contributes to the nociceptive phenotypes of these mice. Previous studies have documented
that mRNAs in the family of neuroligin proteins are being translationally activated by eIF4F in the
nervous system, such as in mice overexpressing eIF4E or lacking 4E-BP2 (Gkogkas et al., 2013). We
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therefore reasoned that the enhanced mechanical nociception in Eif4ebp1-/- mice could be mediated
via enhanced translation of Nlgn mRNAs. Indeed, we found that the expression of neuroligins was
increased in the spinal cord of Eif4ebp1-/- mice without concomitant changes in mRNA levels, indi-
cating enhanced translation. The role of neuroligins in the spinal cord is not well studied. A recent
study showed that knock-down of neuroligin 2, which promotes inhibitory synaptic transmission, in
Figure 5. Reduction of neuroligin 1 levels in Eif4ebp1-/- mice normalizes the enhanced excitatory synaptic transmission. mEPSCs (A) and mIPSCs (B)
were recorded from lamina II spinal neurons of wild-type (WT), Eif4ebp1-/-, Eif4ebp1-/-/Nlgn1+/- and Nlgn1+/- mice. Top: representative traces of
recordings from the four genotypes. Bottom: bar graph showing mEPSC (A) and mIPSC (B) amplitude, frequency and synaptic total charge transfer
(n=11 WT; n=9 Eif4ebp1-/-; n=10 Eif4ebp1-/-/ Nlgn1+/-; n=7 Nlgn1+/-). The increase in mEPSC amplitude and total charge in Eif4ebp1-/- mice is rescued
following deletion of one Nlgn1 allele, whereas mIPSCs are not affected. Data are presented as mean ± SEM. *p<0.05 by Bonferroni post-hoc test
following one-way ANOVA. See also figure supplement 1.
DOI: 10.7554/eLife.12002.010
The following figure supplements are available for Figure 5:
Figure supplement 1. Input resistance and membrane capacitance are not altered in lamina II spinal neurons from Eif4ebp1-/-, Eif4ebp1-/-/Nlgn1+/- and
Nlgn1+/- mice.
DOI: 10.7554/eLife.12002.011
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the spinal cord of naı¨ve rats increases mechanical sensitivity (Dolique et al., 2013). The role of neu-
roligin 1, which promotes excitatory synaptic transmission, in pain processing has not been investi-
gated. Consistent with the higher levels of neuroligin 1, 2 and 3 in mice lacking 4E-BP1, we found
that excitatory and inhibitory spinal synaptic transmission are increased in these animals. Chronic
pain is associated with an increase in the excitatory synaptic drive to dorsal horn neurons (Sandkuh-
ler, 2009). Therefore, in the current study we focused on neuroligin 1 and its role in promoting excit-
atory synaptic transmission in Eif4ebp1-/- mice.
Interestingly, the enhancement of mEPSC amplitude and neuroligin 1 spinal expression in
Eif4ebp1-/- mice was rescued by intrathecal 4EGI-1. In agreement with these results, we also found
that mechanical sensation is reduced in Nlgn1-/- mice, indicating that neuroligin 1 has a pronocicep-
tive function. Strikingly, normalization of neuroligin 1 levels rescued the increased mEPSC ampli-
tudes in Eif4ebp1-/- mice, and partially reversed the mechanical hypersensitivity in these mice. These
data strongly indicate that augmented spinal expression of neuroligin 1 in Eif4ebp1-/- mice contrib-
utes to mechanical hypersensitivity via neuroligin 1-induced upregulation of excitatory synaptic trans-
mission in the spinal cord. The finding that normalization of neuroligin 1 levels only partially reverses
mechanical hypersensitivity in Eif4ebp1-/- mice indicates that additional mechanisms, peripheral or
central, downstream of 4E-BP1/eIF4e contribute to the pain phenotype.
We observed that the increased inhibition in Eif4ebp1-/- mice is solely mediated via enhanced gly-
cinergic, but not GABAergic synaptic transmission (Figure 3C). Similarly to GABAA, glycine recep-
tors mediate fast synaptic inhibition in the spinal cord, where they regulate nociceptive and tactile
sensory processing. Little is known about how synaptic strength of glycinergic synapses is regulated
in vivo. Surprisingly, we found that the inhibitory synaptic transmission was not affected by intrathe-
cal administration of 4EGI-1, possibly because of reduced sensitivity to 4EGI-1 or because inhibitory
synaptic transmission is regulated by 4EGI-1 insensitive processes downstream of 4E-BP1. The differ-
ential regulation of glycinergic synaptic transmission by mTOR/4E-BP1 pathway in the spinal cord is
intriguing, and further studies will be necessary to better understand the precise molecular mecha-
nism of this regulation. However, the increased inhibition in Eif4ebp1-/- mice was not reversed by
normalization of neuroligin 1 expression (Figure 5B), and is thus unlikely to play major role in the
reduced nociceptive thresholds of Eif4ebp1-/- mice, which were reversed by normalization of neuroli-
gin 1 expression (Figure 4E,G).
The threshold for enhancement of electrically-evoked field potentials is lowered in Eif4ebp1-/-
mice. This finding is consistent with studies in the hippocampus showing that 4E-BP2 ablation
engenders the conversion of early-phase long-term potentiation (LTP) into late-phase LTP in the
Schaffer collateral pathway (Banko et al., 2005). Lowered threshold for LTP induction is thought to
be a mechanism contributing to increased responsiveness of spinal circuits under conditions of path-
ological pain (Ji et al., 2003; Sandkuhler, 2009). An mTORC1-mediated increase in eIF4F complex
formation, which leads to the enhancement of synaptic transmission and lowering of the threshold
for the induction of synaptic potentiation, is likely to contribute to abnormal pain processing in mod-
els of chronic pain. Though our study demonstrates an important role of enhanced expression of
neuroligin 1 in the nociceptive phenotype of Eif4ebp1-/- mice, it is conceivable that translational
upregulation of other mRNAs contributes to the regulation of nociception downstream of mTORC1
and ribosome-profiling studies are required to identify these transcripts.
Our data demonstrate that the mTOR/4E-BP/eIF4E pathway controls mechanical, but not thermal
sensitivity. A recent study showed that somatostatin-positive cells, which are enriched in lamina II of
the dorsal horn where they comprise 53% of all glutamatergic excitatory neurons, are required for
sensation of mechanical but not thermal pain (Duan et al., 2014). Interestingly, we found that lamina
II neurons receive stronger excitatory input in Eif4ebp1-/- mice (Figure 3), raising the intriguing pos-
sibility that the effect of 4E-BP1 depletion on mechanical, but not thermal sensation, could be medi-
ated via increased excitatory drive to somatostatin-positive neurons. Conditional deletion of 4E-BP1
in somatostatin positive cells will be required to address this idea.
mTORC1 controls protein synthesis as well as lipid and ribosome biogenesis, autophagy and
mitochondria function (Costa-Mattioli and Monteggia, 2013; Shimobayashi and Hall, 2014). Stud-
ies with rapalogues have shown that mTORC1 is strongly implicated in the development of hyper-
sensitivity states in a variety of pain models (Obara and Hunt, 2014; Price and Geranton, 2009).
However, whether the effects of mTORC1 on nociception are mediated via translation control mech-
anisms or via protein synthesis-independent functions of mTORC1 have remained largely unknown.
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Our study clearly shows that translational regulators (4E-BP1 and eIF4F), acting downstream of
mTOR, control nociception via their effect on mechanical sensation and synaptic responses.
In summary, our results shed important light on the mechanisms by which activation of the
mTOR/4E-BP/eIF4E pathway enhances mechanical pain sensation. We show that 4E-BP1 is a major
functional isoform in the pain pathway, where it represses translation of neuroligins in the spinal
cord. Removal of 4E-BP1 increases neuroligin 1 expression, which in turn promotes excitatory synap-
tic transmission in the spinal cord and leads to mechanical hypersensitivity.
Material and methods
Mice
Eif4ebp1, Eif4ebp2 and Eif4ebp1/2 null mutant mice were backcrossed for more than 10 generations
into a C57BL/6J background (Le Bacquer et al., 2007). Nlgn1 knockout mice were kindly provided
by Craig M. Powell (The University of Texas Southwestern Medical Center, Dallas). Wild-type mice
were littermates of the corresponding knockout mice. All behavioral experiments were performed
on 8–12-week-old mice of both sexes by male experimenters blinded to genotype and drug. Food
and water were provided ad libitum, and mice were kept on a 12:12 hr light/dark cycle (lights on at
08:00 hr). All procedures complied with the Canadian Council on Animal Care guidelines and Inter-
national Association for the Study of Pain, and were approved by McGill University’s Downtown Ani-
mal Care Committee.
Behavioral assays
von Frey Testing: Mice were placed individually in transparent Plexiglas cubicles (5  8.5  6 cm) set
on a perforated steel floor and habituated for 1 hr prior to testing. Nylon monofilaments (Stoelting
#2-#9) were firmly applied to the plantar surface of each hind paw for 0.5 s. The up-down method of
Dixon (Chaplan et al., 1994) was used to estimate the 50% withdrawal threshold (average of two
measurements for both hind paws separated by at least 30 min).
Tail Clip test: A small alligator clip (700 g force) was applied at 1 cm from the base of the tail.
The latency to attack/bite the clip was measured with a stopwatch to the nearest 0.1 sec. Upon
attack, the clip was removed and the animals were returned to their cages.
Radiant Heat Paw-Withdrawal: Mice were placed in cubicles (described above) on a glass floor
and a focused beam of high-intensity light was aimed at the plantar surface of the hind paw. The
intensity of the light was set to 15% or 20% of maximum (IITC Model 390) with a cut-off value of
40 s. The latency to withdraw the hindpaw was measured to the nearest 0.1 s. Measurements con-
sisted of testing both hind paws twice on two separate occasions separated by at least 30 min.
Hot-plate test: Mice were placed into a clear Plexiglas cylinder atop a metal surface (Columbus
Instruments) maintained at 50˚C. The latency to lick or shake either hind paw was measured with a
stopwatch to the nearest 0.1 sec.
Formalin test: Mice were placed into Plexiglas cylinders on a glass floor and habituated for at
least 30 min. Following habituation, all mice were given intraplantar injections of formalin (20 ml,
0.5%) into the left hind paw and placed back into the cylinders. Cameras, placed under the glass
floor, recorded the licking behavior over 60 min. Video files were sampled at 1-min intervals for the
presence or absence of licking behavior in the first 10 sec of each interval. Data are expressed as the
percent of positive (licking) samples. The early phase of the formalin test was defined as 0–10 min.
and the late phase as 10–60 min. post-injection.
Electrophysiology
Electrophysiological recordings of miniature excitatory and inhibitory post-synaptic currents
(mEPSCs and mIPSCS) and dorsal root-evoked field post-synaptic potentials (fPSPs) were made
using lumbar spinal cord tissue. Adult (3 6 months old) male mice were anesthetized with urethane
(2 g/kg) and perfused with ice-cold sucrose-substituted artificial cerebral spinal fluid (sucrose artifi-
cial cerebro-spinal fluid [aCSF]; contains in mM: 252 sucrose, 2.5 KCl, 1.5 CaCl2, 6 MgCl2, 10 d-glu-
cose, bubbled with 95%:5% oxygen:CO2). The lumbar spinal column was removed and immersed in
ice-cold sucrose aCSF after which the spinal cord was quickly removed via laminectomy. For patch-
clamp experiments, the dorsal and ventral roots were removed from the spinal cord and 300 mm-
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thick parasagittal slices were cut from the lumbar portion in ice-cold sucrose aCSF. After cutting, the
spinal cord slices were kept in oxygenated (95% O2, 5% CO2) aCSF (in mM: 126 NaCl, 2.5 KCl, 2
MgCl2, 2 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, 10 d-glucose) at room temperature until recording. For
LTP experiments, the ventral roots and connective tissue were removed from the spinal cord after
laminectomy, and the tissue explant was placed in room temperature aCSF for 1 hr before
experimentation.
In most patch-clamp experiments, slices were continuously perfused (8 ml/min) with oxygenated
aCSF supplemented with tetrodotoxin (1 mM). Lamina II cells were visually identified and patched
with borosilicate pipettes containing (in mM): 110 CsMeSO3, 11 Cs-EGTA, 10 CsCl, 20 HEPES, 2
MgCl2, 1 CaCl2, 4 Mg-ATP, 0.4 Tris-GTP, 0.1% (w/v) Lucifer Yellow; pH was adjusted to 7.2 with
CsOH. Synaptic events were low-pass filtered at 2 kHz and recorded at 10 kHz using a Multiclamp
700B amplifier (Molecular Devices, Sunnyvale, CA), Digidata 1322A digitizer (Molecular Devices),
and pClamp 10 software (Molecular Devices). DL-2-amino-5-phosphonovaleric acid (AP5; 40 mM)
was added to the aCSF to block NMDA receptors. mEPSCs and mIPSCs were recorded at holding
potentials of -70 mV and 0 mV, respectively. For experiments designed to isolate GABAA or glyciner-
gic mIPSCs, strychnine (1 mM) or bicuculline (10 mM) were added to the aCSF, respectively, and visu-
ally identified lamina II cells were patched with pipettes containing (in mM): 120 CsCl, 5 KCl, 11
EGTA, 1 CaCl2, 4 Na-ATP, 0.4 Na-GTP, 10 HEPES and 0.1% Lucifer Yellow (wt/vol), pH 7.2. Stable
3 min recordings of mEPSCs and mIPSCs were selected for analysis in Clampfit 10 (Molecular
Devices).
Electrically-evoked field potentials in the superficial dorsal horn were recorded as previously
described (Bonin and De Koninck, 2014). fPSPs were recorded via a borosilicate glass electrode
inserted into the dorsal side of the spinal cord explant in the dorsal root entry zone. Electrodes were
inserted superficially to a depth of no more than 125 mm from the dorsal surface of the spinal cord
measured with an MPC-200 manipulator (Sutter Instrument Company, Novato, CA, USA). Electrodes
had a tip resistance of 3 4 MW when filled with aCSF. fPSPs were evoked by electrical stimulation of
the dorsal root using a suction electrode that is pulled from borosilicate glass and filled with aCSF,
and placed near the cut end of the dorsal root. Field potentials were amplified with a Multiclamp
700B amplifier (Molecular Devices, Sunnyvale, CA, USA), digitized with a Digidata 1322A (Molecular
Devices), and recorded using pClamp 10 software (Molecular Devices). Data were filtered during
acquisition with a low pass filter set at 1.6 kHz and sampled at 10 kHz. Test stimuli were presented
every 60 s to evoke fPSPs and LTP was evoked by stimulation at 2 Hz for variable lengths of time.
The stimulus intensity was sufficient to activate C-fibers, as indicated by the appearance of a third
distinct fiber volley after the stimulus artifact (Bonin and De Koninck, 2014), while a slightly
(10 20%) higher intensity was used to induce synaptic potentiation. Data were analyzed using
ClampFit 10 software (Molecular Devices). The area of fPSPs relative to baseline was measured from
0 800 ms after the onset of the fPSP.
Drugs
4EGI-1 was purchased from Calbiochem (San Diego, CA) and dissolved first in DMSO (stock solution)
and then in 30% polyethylene glycol. All drugs and chemicals for electrophysiology experiments
were purchased from Sigma-Aldrich (Oakville, ON, Canada).
Western blotting
Tissue extracts for western blotting were prepared in ice-cold homogenization buffer containing (in
mM): 20 Tris-HCl, pH 7.4; 150 NaCl; 1 EDTA; 1% Triton, 5 NaF; 1.5 Na3VO4, and protease inhibitor
cocktail (complete, EDTA-free, Roche Applied Science). Synaptosomes were prepared using Syn-
PER Synaptic Protein Extraction Reagent (Thermo Scientific CAT#8779. Following centrifugation at
12,000  g for 10 min, the supernatant protein concentration was measured and samples containing
equal protein amounts were boiled for 5 min in Laemmli sample buffer and separated by SDS-
PAGE. Following electrophoresis, proteins were transferred to 0.2 mm nitrocellulose membranes.
Membranes were blocked in 5% dry milk powder in Tris-buffered saline containing 0.1% Tween-20
(TBS-T) for 1 hr prior to overnight incubation with the primary antibody. The membranes were then
washed, incubated for 1 h with HRP-conjugated secondary antibody, washed again, treated with
Enhanced Chemiluminescence reagent (Perkin Elmer), and exposed to an autoradiography film
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(Denville Scientific Inc.). All signals were obtained in the linear range for each antibody, quantified
using ImageJ (NIH), and in some experiments normalized to b-actin. The western blot experiments
were performed in triplicate. The antibodies and the dilutions for the western blots used are as fol-
lows: 4E-BP1 (1:1000, Cat#9644, Cell Signaling Technology), 4E-BP2 (1:1000, Cat#2845, Cell Signal-
ing Technology), eIF4E (1:1000, Cat#610269, BD Transduction Laboratories), eIF4G1 (1:1000,
Cat#ab2609 Abcam), neuroligin 1–3 (1:1000, Synaptic Systems), GluA1-2 (1:1000, Alomone labs) and
b-actin (1:5000, Cat#A5441, Sigma).
Measurement of de novo Pprotein sSynthesis
Eight-week-old wild-type and Eif4ebp1-/- mice were injected with puromycin (10 mg/kg, intraperito-
neal, i.p.), and 45 min later DRGs were collected and processed for Western blotting, using anti-
puromycin monoclonal antibody (3RH11, KeraFast). DRGs from mice injected with anisomycin (100
mg/kg i.p, injected 20 min before puromycin) or vehicle were processed in parallel and used as con-
trols. Protein synthesis was determined by measuring total lane signal from 250–15 KDa and sub-
tracting unlabelled protein control. Signals were quantified using ImageJ.
Immunohistochemistry
Mice were deeply anaesthetized and transcardially perfused with 30 ml vascular rinse (0.1% w/v
sodium nitrite in 0.01M perfusion buffer) (for composition see Coˆte´ et al, 1993) and 200 ml fixative
solution (4% paraformaldehyde in 0.1 M PB, pH 7.4) at room temperature (RT). Spinal cords were
extracted trough laminectomy and post-fixed for 2 h at 4˚C. Lumbar levels (L3-L5) of spinal cords
were sectioned using a vibratome and collected in PB saline (PBS) (50-mm thick free floating trans-
verse sections). Sections were washed in PBS containing 0.2% Triton X-100 (PBS-T; Sigma Aldrich)
for 30 min at RT. To block unspecific staining, sections were treated with PBS-T containing 10% nor-
mal goat serum (NGS) for 1 hr at RT. Sections were then incubated with primary antibodies diluted
in PBS-T containing 5% NGS, overnight at 4˚C. Sections were washed in PBS-T for 30 min and incu-
bated with secondary antibodies diluted 1:800 in PBS-T, at RT for 2 hr, protected from light. For iso-
lectin B4 (IB4) staining, sections were incubated with IB4 conjugated to AlexaFluor 546, 1:200
(Molecular Probes) for 1 hr at RT. All steps were carried out under constant shaking. After 30 min of
final washes in PBS-T and 10 min in PBS, sections were mounted with SlowFade Gold
(Invitrogen, Burlington, ON, Canada). The slides were stored protected from light at 4˚C until exam-
ined by use of the Olympus confocal microscope using a 20x oil-immersion objective. Antibodies
used for immunohistochemistry were: glial fibrillary acidic protein (GFAP, 1:2000, GFAP Mouse
mAb, Cell Signalling, #3670), NEUronal Nuclei (NeuN, 1:5000, Mouse Anti-NeuN Antibody, clone
A60, MAB377), calcitonin gene-related peptide (CGRP, 1:1000, Sigma-Aldrich, C8198), substance P
(1:400, Neuromics, MO15094), HTR3A (1:200, Sigma-Aldrich, AV13046), and c-Fos (1:10000, Calbio-
chem, PC38). For detection, species-specific secondary antibodies were used: goat anti-rabbit
Alexa-Fluor 488 (1:800, Invitrogen Molecular probes) and goat anti-mouse Alexa-Fluor 546 (1:800,
Invitrogen Molecular Probes).
Lentivirus packaging and spinal cord injection
Lentiviral vectors for shRNA silencing of 4E-BP1 and a scrambled sequence were obtained from
Sigma. The Sigma MISSION shRNA vectors accession numbers were: mouse 4E-BP1
(TRCN0000075612), and the Non-Target shRNA Control (SHC002). Each shRNA vector was co-trans-
fected into HEK293T cells with the lentivirus packaging plasmids PLP1, PLP2, and PLP-VSVG (Invitro-
gen) using Lipofectamine 2000 (Invitrogen). Viral supernatants were collected 48 and 72 h post-
transfection. Supernatants were filtered through a 0.45 mm nitrocellulose filter either before being
applied to target cells in the presence of polybrene (5 mg/ml), or processed for concentration by
ultracentrifugation at 26,000 rpm/2 h/4˚C with 20% sucrose cushion. Virus concentrates were resus-
pended in serum free media, and aliquots were stored at -80˚C until use. Viral titre (TU/ml) was cal-
culated using puromycin selection of MEFs infected with different viral particle dilutions and stained
with 0.2% crystal violet and 20% methanol solution. Colonies were measured using the CellCount
plugin of ImageJ (NIH). Viral titres were adjusted to 1.5 107 TU/ml for in vivo injections.
For intraparenchymal spinal cord dorsal horn (SCDH) injection, mice were anaesthetized with an
i.p. injection of a cocktail containing xylazine (3.33 mg/ml), ketamine (55.55 mg/ml), and Domitor
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(0.27 mg/ml). The mouse was placed in a spinal frame and a laminectomy was used to remove spi-
nous process VL3 and VL4. Six unilateral injections of 0.25 ml (1  107 viral particles/ml) were admi-
nistesred 0.7 mm apart, at a depth of 0.2 mm (SCDH), using a glass pipette attached to a Hamilton
syringe with plastic tubing at a rate of 0.1 ml/min. To allow for the solution containing viral particles
to diffuse from the tip of the glass pipette into the tissue, the pipette stayed in the tissue for one
additional minute. The syringe was mounted on a microinjector (Nanomite, Harvard Apparatus)
attached to a stereotaxic unit (David Kopf Instruments). The mice were allowed to recover for 1
week before the experiments.
m7GDP pull-down
Lumbar spinal cord was homogenized in lysis buffer containing 40 mM HEPES-KOH (pH 7.5), 120
mM NaCl, 1 mM EDTA, 0.1 mM GDP, 10 mM pyrophosphate, 10 mM b-glycerophosphate,
and 50 mM NaF. Extracts were mixed with 30 ml of m7 GDP-agarose for 1.5 h at 4˚C. The resins
were washed four times and proteins were eluted with SDS–PAGE sample buffer.
Statistical Analyses
All results are expressed as mean ± SEM. All statistical comparisons were made with either Student’s
t-test or one-way or two-way ANOVA, followed by between-group comparisons using t-test or Bon-
ferroni’s post-hoc test, unless otherwise indicated, with p<0.05 as the significance criteria.
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